PD-L1 Expression in Lung Adenocarcinomas Correlates with KRAS Mutations and Th1/Cytotoxic T Lymphocyte Microenvironment

被引：0

作者：

Huynh, Tiffany ^{[1
]}

Morales-Oyarvide, Vicente ^{[2
]}

Uruga, Hironori ^{[1
]}

Bozkurtlar, Emine ^{[1
]}

Gainor, Justin F. ^{[3
]}

Hata, Aaron ^{[3
]}

Mark, Eugene ^{[1
]}

Lanuti, Michael ^{[4
]}

Engelman, Jeffrey A. ^{[5
]}

Mino-Kenudson, Mari ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Pathol, Boston, MA 02114 USA

[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA

[3] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[4] Massachusetts Gen Hosp, Thorac Surg, Boston, MA 02114 USA

[5] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

Immunotherapy; Tumor biology; lung cancer;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ORAL13.01

引用

页码：S198 / S198

页数：1

共 50 条

[1] Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
Schoenfeld, A. J.
Rizvi, H.
Bandlamudi, C.
Sauter, J. L.
Travis, W. D.
Rekhtman, N.
Plodkowski, A. J.
Perez-Johnston, R.
Sawan, P.
Beras, A.
Egger, J. V.
Ladanyi, M.
Arbour, K. C.
Rudin, C. M.
Riely, G. J.
Taylor, B. S.
Donoghue, M. T. A.
Hellmann, M. D.
ANNALS OF ONCOLOGY, 2020, 31 (05) : 599 - 608
[2] PD-L1 Expression in Lung Cancer
Yu, Hui
Boyle, Theresa A.
Zhou, Caicun
Rimm, David L.
Hirsch, Fred R.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : 964 - 975
[3] Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous Carcinomas
Zito Marino, Federica
Rossi, Giulio
Montella, Marco
Botti, Gerardo
De Cecio, Rossella
Morabito, Alessandro
La Manna, Carmine
Ronchi, Andrea
Micheli, Mariacarolina
Salatiello, Giuseppe
Micheli, Pietro
Rocco, Danilo
Accardo, Marina
Franco, Renato
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (03) : 378 - 386
[4] Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas
Yoon, Jiyoung
Suh, Young Joo
Han, Kyunghwa
Cho, Hyoun
Lee, Hye-Jeong
Hur, Jin
Choi, Byoung Wook
THORACIC CANCER, 2020, 11 (04) : 993 - 1004
[5] Regulation of PD-L1 expression in the tumor microenvironment
Yi, Ming
Niu, Mengke
Xu, Linping
Luo, Suxia
Wu, Kongming
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[6] Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
Calles, Antonio
Liao, Xiaoyun
Sholl, Lynette M.
Rodig, Scott J.
Freeman, Gordon J.
Butaney, Mohit
Lydon, Christine
Dahlberg, Suzanne E.
Hodi, F. Stephen
Oxnard, Geoffrey R.
Jackman, David M.
Jaenne, Pasi A.
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) : 1726 - 1735
[7] Bakuchiol inhibits lung cancer by modulating tumor microenvironment and the expression of PD-L1
Lin, Mengxin
Xu, Qian
Luo, Yang
Liu, Gaohua
Hou, Peifeng
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2023, 37 (09)
[8] Validation of the QR1 Antibody for the Evaluation of PD-L1 Expression in Non-Small Cell Lung Adenocarcinomas
Brandone, Nicolas
Mascaux, Celine
Caselles, Kevin
Rouquette, Isabelle
Lantuejoul, Sylvie
Garcia, Stephane
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (01) : 23 - 29
[9] Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma
Tao, Luwei
Miao, Ruoyu
Mekhail, Tarek
Sun, Jingxin
Meng, Lingbin
Fang, Cheng
Guan, Jian
Jain, Akriti
Du, Yuan
Allen, Amanda
Rzeszutko, Brenda L.
Socinski, Mark A.
Chang, Chung-Che
CLINICAL LUNG CANCER, 2020, 22 (04) : E506 - E511
[10] PD-L1 gene expression in Japanese lung cancer patients
Sasaki, Hidefumi
Suzuki, Ayumi
Shitara, Masayuki
Hikosaka, Yu
Okuda, Katsuhiro
Moriyama, Satoru
Yano, Motoki
Fujii, Yoshitaka
BIOMEDICAL REPORTS, 2013, 1 (01) : 93 - 96

← 1 2 3 4 5 →